Clinical trial / 1986
Megadose ascorbic acid increased plasma ascorbate but did not alter PMN chemotaxis or experimental gingivitis compared to placebo.
A double-blind study evaluated the effects of megadose ascorbic acid supplementation in individuals with a baseline mean daily ascorbate intake approximately twice the recommended daily allowance. Compared to placebo, the supplemented group showed a significant increase in plasma vitamin levels. However, no significant differences were observed between groups regarding polymorphonuclear neutrophil chemotaxis or clinical and biochemical responses to experimental gingivitis.
- Study type
- Double-blind controlled trial
- Who was studied
- Individuals with mean daily ascorbate intake about twice the RDA
- What was measured
- Plasma ascorbate, PMN chemotaxis, inflammatory progression of gingivitis
THE PAPER
The effects of megadoses of ascorbic acid on PMN chemotaxis and experimental gingivitis.
Vogel RI, Lamster IB, Wechsler SA, Macedo B, Hartley LJ, Macedo JA. J Periodontol, 1986.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.